NEW DRUG DEVELOPMENT IN THE UNITED-STATES FROM 1963 TO 1990

被引：32

作者：

DIMASI, JA ^{[1
]}

BRYANT, NR ^{[1
]}

LASAGNA, L ^{[1
]}

机构：

[1] TUFTS UNIV,DEPT PSYCHIAT,BOSTON,MA 02111

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1991年 / 50卷 / 05期

关键词：

D O I：

10.1038/clpt.1991.172

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：471 / 486

页数：16

共 13 条

[1]

CLARKE E, 1903, NDA PIPELINE

[2] COST OF INNOVATION IN THE PHARMACEUTICAL-INDUSTRY [J].

DIMASI, JA ;

HANSEN, RW ;

GRABOWSKI, HG ;

LASAGNA, L .

JOURNAL OF HEALTH ECONOMICS, 1991, 10 (02) :107-142

[3] NOVEL MEDICINES MARKETED IN THE UK (1960-87) [J].

LIS, Y ;

WALKER, SR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (03) :333-343

[4] NEW DRUG DEVELOPMENT IN THE UNITED-STATES, 1963 THROUGH 1984 [J].

MATTISON, N ;

TRIMBLE, AG ;

LASAGNA, L .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (03) :290-301

[5] NEW DRUG DEVELOPMENT DURING AND AFTER A PERIOD OF REGULATORY CHANGE - CLINICAL RESEARCH ACTIVITY OF MAJOR UNITED-STATES PHARMACEUTICAL FIRMS, 1958 TO 1979 [J].

MAY, MS ;

WARDELL, WM ;

LASAGNA, L .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (06) :691-700

[6] SUCCESS RATES IN THE UNITED-STATES DRUG DEVELOPMENT SYSTEM [J].

SHECK, L ;

COX, C ;

DAVIS, HT ;

TRIMBLE, AG ;

WARDELL, WM ;

HANSEN, R .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (05) :574-583

[7] DEVELOPMENT OF NEW DRUGS ORIGINATED AND ACQUIRED BY UNITED-STATES-OWNED PHARMACEUTICAL FIRMS, 1963-1976 [J].

WARDELL, WM ;

DIRADDO, J ;

TRIMBLE, AG .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :270-277

[8]

WARDELL WM, 1978, CLIN PHARMACOL THER, V24, P133

[9]

WARDELL WM, 1982, CLIN PHARMACOL THER, V32, P7

[10]

1984, FED REG, V49

← 1 2 →